10200 Macromolecules, Vol. 43, No. 24, 2010
Communication
than when under strong base conditions. The hydrolysis
proceeded in the time range from 0 to 19 days. The slow
degradation pattern with enhancement of fluorescence inten-
sity of PMFT shows a potential in vivo application in biolog-
ical field, especially in drug controlled release.
Acknowledgment. The authors are grateful for the National
Natural Science Foundation of China (Nos. 20725308, 21033010,
and 90913014).
References and Notes
The photostability of PMFT was studied under UV irra-
diation with 365 nm as light source. As depicted in Figure 4a,
although the fluorescence intensity of PMFT at 384 nm
decreased with the irradiation, the fluorescence remained
40% upon continuously irradiating for 4 min. Thus, the fairly
good photostability of PMFT makes it possible for fluores-
cence imaging use. Because of the importance for in vivo use,
the biocompatibility of PMFT was studied by a typical MTT
assay method.28 As shown in Figure 4b, the PMFT exhibits
little cytotoxicity as the concentration increases from 12.5 to
50 μM. Even at high PMFT concentration (100 μM), the cell
viability still remains about 60%. The degradation products
of PMFT are the monomer MF and terephthalic acid, where
terephthalic acid shows little cytotoxicity; thus, the cytotox-
icity of MF was also studied. Even at high MF concentra-
tion (50 μM), the cell viability still remains above 60%, so we
believe that both polymer and degradable products have little
cytotocixity in a certain range of concentration. In compar-
ison with the cytotoxicity of quantum dots (QDs)25 and
photobleaching properties of organic dyes, the PMFT has
both acceptable cytotoxicity and photostability.
(1) Thomas, S. W., III; Joly, G. D.; Swager, T. M. Chem. Rev. 2007,
107, 1339.
(2) Liu, B.; Bazan, G. C. Chem. Mater. 2004, 16, 4467.
(3) Ho, H. A.; Najari, A.; Leclerc, M. Acc. Chem. Res. 2008, 41, 168.
(4) Duan, X.; Liu, L.; Feng, F.; Wang, S. Acc. Chem. Res. 2010, 43, 260.
(5) Ho, H. A.; Dore, K.; Boissinot, M.; Bergeron, M. G.; Tanguay,
R. M.; Boudreau, D.; Leclerc, M. J. Am. Chem. Soc. 2005, 127, 12673.
(6) Nilsson, K. P. R.; Inganas, O. Nature Mater. 2003, 2, 419.
(7) Gaylord, B. S.; Heeger, A. J.; Bazan, G. C. Proc. Natl. Acad. Sci.
U.S.A. 2002, 99, 10954.
(8) Wang, S.; Gaylord, B. S.; Bazan, G. C. J. Am. Chem. Soc. 2004,
126, 5446.
(9) Wang, D. L.; Gong, X.; Heeger, P. S.; Rininsland, F.; Bazan, G. C.;
Heeger, A. J. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 49.
(10) Jiang, H.; Taranekar, P.; Reynolds, J. R.; Schanze, K. S. Angew.
Chem., Int. Ed. 2009, 48, 4300.
(11) Xu, H.; Wu, H. P.; Huang, F.; Song, S. P.; Li, W. X.; Cao, Y.; Fan,
C. H. Nucleic Acids Res. 2005, 33, e83.
(12) Bunz, U. H. F. Chem. Rev. 2000, 100, 1605.
(13) Kim, I. B.; Wilson, J. N.; Bunz, U. H. F. Chem. Commun. 2005,
1273.
(14) Achyuthan, K. E.; Bergstedt, T. S.; Chen, L.; Jones, R. M.;
Kumaraswamy, S.; Kushon, S. A.; Ley, K. D.; Lu, L.; McBranch,
D.; Mukundan, H.; Rininsland, F.; Shi, X.; Xia, W.; Whitten,
D. G. J. Mater. Chem. 2005, 15, 2648.
(15) Guo, Z. Q.; Zhu, W. H.; Tian, H. Macromolecules 2010, 43, 739.
(16) Feng, X. L.; Tang, Y. L.; Duan, X. R.; Liu, L. B.; Wang, S.
J. Mater. Chem. 2010, 20, 1312.
(17) Moon, J. H.; McDaniel, W.; MacLean, P.; Hancock, L. E. Angew.
Chem., Int. Ed. 2007, 46, 8223.
(18) McRae, R. L.; Phillips, R. L.; Kim, I. B.; Bunz, U. H. F.; Fahrni,
C. J. J. Am. Chem. Soc. 2008, 130, 7851.
(19) Yang, J.; Zhang, Y.; Gautam, S.; Liu, L.; Dey, J.; Chen, W.;
Mason, R. P.; Serrano, C. A.; Schug, K. A.; Tang, L. P. Proc. Natl.
Acad. Sci. U.S.A. 2009, 106, 11818.
(20) Gao, X. H.; Yang, L. L.; Petros, J. A.; Marshal, F. F.; Simons,
J. W.; Nie, S. M. Curr. Opin. Biotechnol. 2005, 16, 63.
(21) Gaumet, M.; Gurny, R.; Delie, F. Int. J. Pharm. 2007, 342, 222.
(22) Ogura, Y.; Kimura, H. Surv. Ophthalmol. 1995, 39, S17.
(23) Ghoroghchian, P. P.; Frail, P. R.; Li, G. Z.; Zupancich, J. A.;
Bates, F. S.; Hammer, D. A.; Therien, M. J. Chem. Mater. 2007, 19,
1309.
(24) Rhyner, M. N.; Smith, A. M.; Gao, X. H.; Mao, H.; Yang, L. L.;
Nie, S. M. Nanomedicine 2006, 1, 209.
(25) Jamieson, T.; Bakhshi, R.; Petrova, D.; Pocock, R.; Imani, M.;
Seifalian, A. M. Biomaterials 2007, 28, 4717.
Conclusions. A new water-soluble degradable polyester
consisting of fluorescent 2,7-di(40-phenylmethanol)-9,9-bis-
(60-(300-methylimidazolium)hexanyl)fluorene chromophore
and degradable ester spacer in backbone (PMFT) has been
designed and successfully synthesized via facile operations.
The fluorescence of the PMFT is from a fluorescent phenyl-
fluorenyl moiety, and its water solubility is obtained by
introducing charged groups in the side chain of the polymer.
The PMFT is easily degraded in basic conditions, which was
1
confirmed by H NMR spectra and fluorescence measure-
ment. Degradation of PMFT was verified by 1H NMR
spectroscopy through following the proton chemical shift
of the benzyl -CH2- group adjacent to the ester moiety in
PMFT (5.47 ppm) to 4.56 ppm for the methylene proton
resonance in the MF degration product. Since fluorescence
quantum efficiency of monomer MF (76%) is much higher
than that of polymer PMFT (2%), the release of MF from
the polymer main chain by PMFT degradation leads to
the enhancement of emission intensity of PMFT solution. In
physiological environment (pH = 7), PMFT hydrolyzes at
a rather slow rate than when under strong basic conditions
(10 min). Because of its fluorescent and degradable properties,
PMFT may have various in vivo applications in biological and
biomedical fields such as drug delivery and cell imaging.
(26) Zheng, S. Y.; Shi, J. M.; Mateu, R. Chem. Mater. 2000, 12, 1814.
(27) Lakowicz, J. R. Principles of Fluoresence Spectoscopy, 3rd ed.;
Springer: New York, 2006.
(28) Denizot, F.; Lang, R. J. Immunol. Methods 1986, 89, 271.
(29) Arnt, L.; Tew, G. N. J. Am. Chem. Soc. 2002, 124, 7664.
(30) Chu, Q.;Pang, Y. J. Polym. Sci., Part A: Polym. Chem. 2006, 44, 2338.